J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 47(3); 2004 > Article
Heo: Pharmacologic Management of Cancer Pain

Abstract

Flexibility is important in managing cancer pain. As patients vary in diagnosis, stage of disease, responses to pain and treatments, and personal likes and dislikes, management of cancer pain must be individualized. Patients, their families, and their health care providers must work together closely to manage a patient's pain effectively. The World Health Organization (WHO) developed a 3-step approach for pain management based on the severity of the pain : ① For mild to moderate pain, the doctor may prescribe a Step 1 pain medication such as aspirin, acetaminophen, or a nonsteroidal anti-inflammatory drug (NSAID). ② When pain lasts or increases, the doctor may change the prescription to a Step 2 or Step 3 pain medication. Most patients with cancer-related pain will need a Step 2 or Step 3 medication. The doctor may skip Step 1 medications if the patient initially has moderate to severe pain. ③ The patient should take doses regularly, "by mouth, by the clock" (at scheduled times), to maintain a constant level of the drug in the body ; this will help prevent recurrence of pain. If the patient is unable to swallow, the drugs are given by other routes (for example, by infusion or injection).

References

1. WHO. Cancer pain relief 1996;2nd ed.

Figure 1
jkma-47-268-g001-l.jpg
Figure 2
jkma-47-268-g002-l.jpg
Figure 3
jkma-47-268-g003-l.jpg
Figure 4
jkma-47-268-g004-l.jpg
Table 1
jkma-47-268-i001-l.jpg

* Empirically, transdermal fentanyl 100 µg/h = 2~4 mg/h intravenous morphine

Table 2
jkma-47-268-i002-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next